ArticleOncotarget2017

Interleukin-22 promotes aerobic glycolysis associated with tumor progression via targeting hexokinase-2 in human colon cancer cells.

Yulin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.